Drug Interactions & Safety at Psych Congress 2026
6 sessions on drug interactions & safety · September 15–19, 2026, New Orleans, LA. Compare drug interactions & safety at other meetings →
Tuesday, September 15
Lecture · Difficult Medicines
Difficult Medicines: The Art and Science of Lithium Therapy
Practical deep dive on lithium's mechanisms and dosing precision, including monitoring, toxicity mitigation, adherence, and use in special populations.
Wednesday, September 16
Symposium · SRSF Partner Session
Solving Clinical Challenges: Untangling Sleep Problems in Psychiatric Practice
Philip Gehrman · Rakesh Jain · Hara E. Oyedeji
Case-based session on sorting whether insomnia or hypersomnia reflects medication effects, primary sleep disorders, circadian disruption, or worsening psychiatric illness, and when to order sleep studies. Developed with the Sleep Research Society Foundation.
Thursday, September 17
Lecture · Difficult Medicines
Difficult Medicines: Navigating the Complexities of Clozapine
Deep dive into clozapine for treatment-resistant schizophrenia — initiation, monitoring requirements, side-effect management, and adherence — grounded in real-world cases.
Friday, September 18
Symposium · Difficult Medicines
Difficult Medicines: Understanding the Opioid Treatment Landscape for Safe and Effective Outcomes
Elizabeth Langmore-Avila · Arwen Podesta
Compares methadone, buprenorphine, and naltrexone for opioid use disorder, covering patient selection, titration, cardiac and overdose considerations, sedative co-prescribing, and transitions between agents.
Saturday, September 19
Symposium · Integrative Psychiatry
Mind & Metabolic Matters: Practical Guidance on Prescribing GLP-1s in Psychiatry
Brittany Albright · Jonathan M. Meyer
Clinic-ready framework for GLP-1 and dual-incretin use in psychiatric patients: selection, titration, adverse-effect management, and psychiatric considerations including eating disorder risk, mood monitoring, and craving implications.
Symposium · ISRP Partner Session
Perinatal Psychiatry in Practice: Balancing Mother and Fetus in Pharmacotherapy
Evidence-based guidance on psychotropic use in pregnancy and lactation, including dosing, risk communication, and collaboration with obstetric providers. Developed with the International Society of Reproductive Psychiatry.
Other topics at this meeting
Depression 10Neuroscience & Mechanisms 10Schizophrenia & Psychosis 9Measurement-Based Care & Diagnosis 8Drug Pipeline & Clinical Trials 7Sleep & Insomnia 7ADHD 6Bipolar Disorder 6Lifestyle & Integrative Psychiatry 6Psychotherapy 6Antipsychotic Prescribing 5Anxiety Disorders 5